Crystal Arlette Montás and Mike Evers join ci as Designers, continuing its rapid expansion of its Science & Technology Practice by ci design

CI Design Names Montás as Designer
Boston and Baltimore-based firm continues to expand its Science & Technology staff

BOSTON and BALTIMORE (June 12, 2019) – In its continuing expansion of its Science & Technology (S&T) practice, CI Design has named Crystal Arlette Montás as Designer, the international architectural design firm announced today. Montás will be based in the firm’s Boston office.

Montás’ experience in modeling, surveying and team coordination will enhance the services CI’s rapidly growing S&T division offers to clients in this very specialized field, said Raffe Khazadian, AIA, principal.

“Crystal is an exciting young talent, and we’re delighted to add her to our team,” Khazadian said.

Prior to joining CI Design, Montás was a designer with TRIA, where she focused on lab equipment surveys, models, construction administration, rendering creation and more. She holds a Master of Architecture with distinction from the Wentworth Institute of Technology, where she also earned a Bachelorr of Science in Architecture.

“The chance to work with Raffe Khazadian, a leader in S&T design, as well as with all of the professionals at CI is the opportunity of a lifetime,” Montás said. “I can’t wait to begin.”

CI_new_Montas_Evers.jpg

CI Design Continues Rapid Boston Team Expansion with Mike Evers
The international architectural and design firm names Evers as Designer

BOSTON and BALTIMORE (June 12, 2019) – CI Design has named Mike Evers Designer in its Boston office, continuing the location’s rapid expansion.

“Boston and all of New England not only is a wellspring of opportunity, but also of architecture and design talent,” said Christopher Ladd, AIA, NCARB, vice president and principal. “We welcome Mike as we know he will contribute immensely to both our commercial and science & technology practices.”

Evers most recently served as a designer with TRIA, working on various projects from concept to construction, and researching, creating and introducing new technological tools to the office. Prior experience includes working with Boston College Capital Projects Management.

“CI’s leadership is remarkably open to new ideas and tools,” Evers said. “I’m excited to work with the best in the business in commercial and S&T design.”

Evers earned both Bachelor of Science and a Masters of Architecture degrees from the Wentworth Institute of Technology.

For more than 25 years, CI Design’s team has offered innovative, sustainable and value-creating design solutions for S&T and other commercial facilities, including wet and dry labs, specialized testing facilities, and control rooms for chemical storage, distribution and treatment. Clients have included GT Advanced Technologies, Insulet Corp., Merck/Millipore, Gillette and other private and public companies and educational institutions.

###

ABOUT CI DESIGN, INC.

CI Design is an international architectural design firm offering award-winning planning, architecture and interior design services to a diverse base of clients. For more than 25 years, CI Design has been a recognized leader in Science & Technology, retail and mixed-use project design across the globe.

The CI Design team recently completed the world headquarters and U.S. clean manufacturing facility of Insulet Corporation, and is working on Phase 3 of the development. It continues to provide design support for clients including Millipore, IPG Photonics and Raytheon, as well as various confidential life science projects. The firm is also working on several mixed-use developments including the 4-million-square-foot Metropica in Sunrise, Fla., and the 1.2 million square-foot expansion to North Hills In Raleigh, N.C. 

CI Design has offices in Boston and Baltimore, for additional information, go to  www.ci-designinc.com . 

The River Club, Mid Atlantic Real Estate Journal's Development of the Month by ci design

River Club Rendering.jpg

From underutilized parcel to a new community – the journey of the River Club, now under construction in Bogota, N.J., is one of patience, persistence and flexible design.

The mixed-use complex at West Fort Lee Road and the Hackensack River will include 421 luxury apartments, from studios through 3 bedrooms, including 42 affordable units, adding much-needed density to the region.

Designed by master planner and architect of record CI Design, Baltimore, the gated development will consist of four, four- and five-story residential buildings, with 8,000 square feet of ground floor retail, a dog park, and a 2,000-foot public walkway along the river that will link downtown Bogota to downtown Hackensack. A community clubhouse will feature an indoor/outdoor fireplace, yoga studio, media room and luxury pool terrace including an infinity-edge pool.

CLICK TO READ FULL STORY AT THE MID ATLANTIC REAL ESTATE JOURNAL:

Insulet Celebrates New Global Headquarters and U.S. Manufacturing Facility by ci design

Insulet Celebrates New Global Headquarters and U.S. Manufacturing Facility in Acton, MA

The Insulet Corporation held their official ribbon cutting ceremony last week to celebrate the grand opening of the Company’s new global headquarters and U.S. manufacturing facility. Ci provided full architecture and interior design for the entire project from concept through construction.

May 2, 2019, 6:00 AM EDT

Insulet Celebrates New Global Headquarters and U.S. Manufacturing Facility in Acton, MA

Over $200 Million Investment in Massachusetts Creates Hundreds of Local Manufacturing Jobs and a Launchpad for New Product Innovation

Business Wire

ACTON, Mass. -- May 2, 2019

Insulet Corporation (NASDAQ: PODD) (Insulet), the global leader in tubeless insulin pump technology with its Omnipod^® Insulin Management System, will host a ribbon cutting ceremony today to celebrate the official grand opening of the Company’s new global headquarters and U.S. manufacturing facility in Acton, Massachusetts.

The new facility, located on a 26-acre site, which represents an over $200 million investment in Massachusetts, has already created hundreds of local jobs, and provides additional manufacturing capabilities closer to Insulet’s large and growing U.S. customer base. The new U.S. manufacturing operation is also expected to drive operating efficiencies and increase productivity. The Company recently began production.

Massachusetts Governor, Charlie Baker, will join Insulet speakers Shacey Petrovic, President and Chief Executive Officer, and Chuck Alpuche, Executive Vice President and Chief Operating Officer, to commemorate the ribbon cutting ceremony. Other special guests include: Massachusetts State Senator Jamie Eldridge; Travis McCready, President and Chief Executive Officer of the Massachusetts Life Sciences Center; dignitaries from the Commonwealth of Massachusetts; and members of Insulet’s loyal Podder community.

“As a global hub for innovation and research, Massachusetts is well-positioned to expand its advanced manufacturing footprint,” said Governor Charlie Baker. “Our Administration has prioritized efforts to create an environment that
supports the growth of companies like Insulet, and we are glad to see them open this new facility and create jobs here in the Commonwealth.”

“We are honored to call Massachusetts our home and are truly grateful for the strong partnership with the Commonwealth of Massachusetts and town of Acton. They have been tremendous supporters of this monumental milestone for Insulet,” said Shacey Petrovic, President and Chief Executive Officer. “Our new global headquarters and U.S. manufacturing facility is a launchpad for continued growth and exciting innovation and we’re proud to be contributing to the economy by creating hundreds of local jobs.”

For more about Insulet’s future innovation pipeline, please visit myomnipod.com/innovation.

About Insulet Corporation:

Insulet Corporation (NASDAQ: PODD), headquartered in Massachusetts, is an innovative medical device company dedicated to making the lives of people with diabetes and other conditions easier through the use of its Omnipod product platform. The Omnipod Insulin Management System provides a unique alternative to traditional insulin delivery methods. With its simple, wearable design, the disposable Pod provides up to three days of non-stop insulin delivery, without
the need to see or handle a needle. Insulet also leverages the unique design of its Pod, by tailoring its Omnipod technology platform for the delivery of non-insulin subcutaneous drugs across other therapeutic areas.

For more information, please visit: www.insulet.com and www.myomnipod.com.

Forward-Looking Statement:

This press release may contain forward-looking statements concerning Insulet's expectations, anticipations, intentions, beliefs or strategies regarding the future. These forward-looking statements are based on its current expectations and beliefs concerning future developments and their potential effects on Insulet. There can be no assurance that future developments affecting Insulet will be those that it has anticipated. These forward-looking statements involve a number of risks, uncertainties (some of
which are beyond its control) or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements, and other risks and uncertainties
described in its Annual Report on Form 10-K, which was filed with the Securities and Exchange Commission in February 2019 in the section
entitled "Risk Factors," and in its other filings from time to time with the Securities and Exchange Commission. Should one or more of these risks or uncertainties materialize, or should any of its assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. Insulet undertakes no obligation to publicly update or revise any forward-looking statements.

© 2019 Insulet Corporation. Omnipod, and the Omnipod logo are trademarks or registered trademarks of Insulet Corporation. All other trademarks are the property of their respective owners. All rights reserved.

View source version on businesswire.com:
https://www.businesswire.com/news/home/20190502005041/en/

Contact:

Investor and Corporate Communications Contact:
Deborah R. Gordon, 978-600-7717
Vice President, Investor Relations and Corporate Communications
dgordon@insulet.com

Consumer Contact:
Natalie Toomey, 978-600-7421
Marketing Manager, Global Public Relations & Field Programs
ntoomey@insulet.com

Sean Cullen Joins CI Design as Senior Project Designer, continuing to expand its Science & Technology Practice by ci design

BOSTON and BALTIMORE (April 19, 2019) – Sean P. Cullen has joined CI Design as Senior Project Designer, continuing the international architectural design firm’s rapid expansion of its Science & Technology practice area.

Over more than two decades, Cullen has become renowned for integrating aesthetics with the highly technical design needs of biopharmaceutical facilities, labs and clean rooms, said John Larsen, AIA, NCARB, president of CI Design. Cullen will be based out of the firm’s Boston office.

CI_new_Cullen.jpg

“Sean has a distinctive knack for bringing warmth and a human element to what could be cold, impersonal facilities,” Larsen said. “This dovetails with our own S&T design philosophy. We’re looking forward to working with him as we extend our already strong and growing specialization.”

Prior to joining CI Design, Cullen was a project designer with boutique biopharma lab/technology design firm TRIA. As the key first hire for the firm, he established its architectural production standards, templates and methods, and worked with clients including Procter & Gamble/Gillette, Entegris, Moderna Therapeutics, Sartorious, Synageva BioPharma and Capital Group Properties. Previously, he served in design roles with Signer Harris Architects (which was acquired by Perkins+Will) and I Design & Associates.

“We are delighted to bring Sean into the CI Design family,” adds Christopher Ladd, AIA, NCARB, CI Design vice president and principal. “In addition to his gifts as a designer, he is known for mentoring younger staff, which will be critical as we continue to grow our S&T practice.”

For more than 25 years, CI Design’s team has offered innovative, sustainable and value-creating design solutions for S&T and other commercial facilities, including wet and dry labs, specialized testing facilities, and control rooms for chemical storage, distribution and treatment. Clients have included Insulet Corp., EMD Millipore, Sigma Millipore, P&G/Gillette, Pfizer, ARRIS and other private and public companies. CI Design is a period of rapid expansion, especially in the S&T practice area, with two principals, Raffe Khazadian and Daniel Madru, joining the practice in recent months.

“I’m excited to to work with extraordinarily gifted design professionals,” Cullen said. “CI is already a leading S&T firm and I am looking forward to being a part of its continued growth.”

Cullen earned a Bachelor of Architecture degree from the Boston Architectural Center, and a Bachelor of Arts degree in English from the University of Pennsylvania.

ABOUT CI DESIGN, INC.

CI Design is an international architectural design firm offering award-winning planning, architecture and interior design services to a diverse base of clients. For more than 25 years, CI Design has been a recognized leader in Science & Technology, retail and mixed-use project design across the globe.

The CI Design team recently completed the world headquarters and U.S. clean manufacturing facility of Insulet Corporation, and is working on Phase 3 of the development. It continues to provide design support for clients including Millipore, IPG Photonics and Raytheon, as well as various confidential life science projects. The firm is also working on several mixed-use developments including the 4-million-square-foot Metropica in Sunrise, Fla., and the 1.2 million square-foot expansion to North Hills In Raleigh, N.C. 

CI Design has offices in Boston and Baltimore, for additional information, go to  www.ci-designinc.com .